Request an Appointment

Harry H. Yoon, M.D.

  1. Oncologist

Departments

Location

  1. Rochester, Minnesota

Languages

English

Existing patients

  • Gastrointestinal cancers
  • Esophageal/gastroesophageal junction or gastric cancers
  • Colon cancer
  • Rectal cancer
  • Pancreaticobiliary cancer
  • Small bowel cancer
  • Cancer of unknown primary
  1. 2008
    Clinical Post Doctoral Fellowship - Medical OncologyThe Johns Hopkins University School of Medicine
  2. 2006
    MHSGraduate Training Program in Clinical Investigation (GTPCI), Johns Hopkins School of Public Health
  3. 2004
    Internship/Residency - Internal MedicineTraditional Program, Yale-New Haven Hospital, Yale University School of Medicine
  4. 2001
    MDYale University School of Medicine
  5. 1993
    BS - Molecular Biophysics & BiochemistryYale College

Certifications

  1. 2007
    Medical OncologyAmerican Board of Internal Medicine

Awards and honors

  1. 2011
    Charles F. and Marcia L. Forcey Career Development Award in Esophageal Cancer ResearchMayo Clinic Development Department and Cancer Center
  2. 2010
    Top Educator 2010Internal Medicine Residency Program, Department of Internal Medicine
  3. 2008
    Diagnostic Development Tutorial: From Hypothesis to ProductAACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics, American Association for Cancer Research
  4. 2008
    Paul Calabresi (K12) Clinical Translational Research Career Development ProgramMayo Clinic Cancer Center
  5. 2007
    Young Investigator AwardAmerican Society of Clinical Oncology
  6. 2001
    ACP/ASIM Internal Medicine AwardConnecticut Chapter ACP-ASIM
  7. 1989
    Cum LaudeYale College

Professional memberships

  1. 2022
    Session leaderMayo Clinic GI Disease Groups
  2. 2022
    National Advisory BoardDaiichi Sankyo and AstraZeneca
  3. 2022 - present
    GI Executive Advisory CouncilAmgen Pharmaceuticals
  4. 2022 - present
    Global Steering Committee MemberBeiGene
  5. 2021
    Esophageal Cancer Advisory BoardBeiGene
  6. 2021
    Esophageal Cancer Advisory BoardNovartis Pharmaceuticals
  7. 2021
    Global Gastric Cancer Advisory BoardBristol Myers Squibb
  8. 2021
    National Mock FDA Advisory BoardMerck & Co., Inc.
  9. 2021
    Gastric Cancer Advisory BoardZymeworks
  10. 2021
    National Gastric Cancer Advisory BoardOncXerna
  11. 2020
    Global Gastric Cancer Advisory BoardZymeworks
  12. 2020
    Global Gastric Cancer Advisory BoardMacrogenics
  13. 2019 - present
    Active MemberGI Disease Group Steering Committee
  14. 2019
    MemberAstellas Pharma Inc
  15. 2019
    MemberALX Oncology
  16. 2019
    MemberFivePrime
  17. 2019
    Advisory Board MemberMerck Research Laboratories
  18. 2019 - present
    Steering Committee MemberMacrogenics
  19. 2019 - present
    MemberEsophageal and Gastric Cancer Committee, National Comprehensive Cancer Network
  20. 2018 - present
    Co-ChairBeiGene
  21. 2018 - present
    Steering Committee MemberMerck Research Laboratories
  22. 2018 - present
    Steering Committee MemberLSK Biopharma
  23. 2017 - present
    ChairGastroesophageal Cancer Disease Group, Mayo Clinic Cancer Center
  24. 2017 - present
    MemberGI Lab Med & Pathol Disease-Oriented Group
  25. 2016 - 2019
    Alliance GI RepresentativeMayo Clinic Cancer Center, Alliance for Clinical Trials in Oncology, Esophagogastric Task Force of the Gastrointestinal Steering Committee
  26. 2015 - 2020
    PanelistNational Comprehensive Cancer Network Occult Primary Guidelines Panel
  27. 2015 - present
    Faculty AdvisorThe Angiogenesis Foundation Center of Excellence
  28. 2014
    Advisory Board MemberLilly Oncology
  29. 2014 - 2017
    MemberGastric-Esophageal Cancer Specialty Council
  30. 2014
    AdvisorFivePrime Gastric Cancer Advisory Board
  31. 2013 - present
    MemberMerrimack MM-111 Translational Science Steering Committee
  32. 2012 - 2014
    MemberAcademic and Community Cancer Research United, Mayo Clinic Cancer Center
  33. 2012
    MemberTask Force - Standardizing clinical management of patients with esophageal cancer
  34. 2011
    Advisory Board MemberGenentech USA
  35. 2011 - present
    MemberAcademic and Community Clinical Research United
  36. 2010 - 2014
    MemberNCI Task Force, National Cancer Institute, National Institutes of Health
  37. 2010
    Advisory Board MemberGenentech USA
  38. 2009 - present
    Ad Hoc ReviewerMayo Clinic Scientific Review Committee
  39. 2008 - present
    MemberAmerican Association for Cancer Research
  40. 2008 - 2014
    MemberGI Cancers DOG, Disease/Discipline Oriented Groups (DOGs), Mayo Clinic Cancer Center
  41. 2008 - 2012
    MemberNorth Central Cancer Treatment Group, NCI Cooperative Group Affiliation, National Cancer Institute
  42. 2008 - present
    MemberEsophageal Adenocarcinoma Barretts Esophagus Consortium
  43. 2008 - present
    MemberMinnesota Medical Association
  44. 2006 - present
    MemberAmerican Society of Clinical Oncology

Publications

See my publications

Research activities

See a description of research activities.